SYS-CON MEDIA Authors: Yeshim Deniz, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

USDM Life Sciences Vice President of Unique Device Identification Practice, Jay Crowley, Will Discuss UDI Final Rule at GS1 Global Forum

Jay Crowley Is the Architect of FDA's UDI Final Rule

SANTA BARBARA, CA -- (Marketwired) -- 02/17/14 -- USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce Jay Crowley, Vice President of USDM Life Sciences Unique Device Identification Practice, will discuss UDI regulations at the GS1 Global Forum in Brussels, Belgium on February 17th at 16:15 and February 19th at 13:30.

"As UDI rolls out globally, I'm looking forward to working closely with my colleagues at GS1 Global and the GS1 Member Organizations to help develop and implement global UDI standards," said Crowley. "All of us at USDM are looking forward to working with stakeholders to help their organizations implement UDI in a way that helps them realize the global benefits of UDI."

As Vice President of the UDI Practice at USDM Life Sciences, Crowley helps medical device manufacturers achieve regulatory compliance as well as internal benefits and competitive advantage around UDI implementation.

Crowley held various positions over his nearly 27 years at FDA. Most recently, he was Senior Advisor for Patient Safety, in FDA's Center for Devices and Radiological Health. Crowley had primary responsibility for the development and implementation of FDA's Unique Device Identification System.

The GS1 Global Forum is at the Crowne Plaza in Brussels, Belgium February 17-21, 2014.

About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. USDM Life Sciences has more than 13 years of experience supplying our clients in the life science industry with compliance services during each phase of their drug and product development cycle while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. For more information, please visit www.usdm.com.

Add to Digg Bookmark with del.icio.us Add to Newsvine

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.